Author Question: Canadian researcher Hans Selye made which of the following important contributions to the field of ... (Read 81 times)

geoffrey

  • Hero Member
  • *****
  • Posts: 880
Canadian researcher Hans Selye made which of the following important contributions to the field of health psychology?
 
  a) The distinction between distress and eustress
  b) The distinction between stressors that are psychogenic or neurogenic
  c) The distinction between the effects of controllable and uncontrollable stressors
  d) The goodness of fit hypothesis

Question 2

Colin Ross' study revealed that among the least common dissociative experiences was:
 
  a) Uncertainty about whether you actually did something or just thought about doing it
  b) Being in a familiar place but finding it unfamiliar
  c) Ignoring pain
  d) Noticing that things that are typically difficult to do are actually done easily



cici

  • Sr. Member
  • ****
  • Posts: 325
Answer to Question 1

a

Answer to Question 2

b



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Critical care patients are twice as likely to receive the wrong medication. Of these errors, 20% are life-threatening, and 42% require additional life-sustaining treatments.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library